The news is a growth re-acceleration story: Q1 revenue +85% and 206 $1M+ deals, plus TCV $2.41B. The market is already ...
VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue ...
Explore how organoids are unlocking new possibilities in modern drug discovery by improving disease modelling within ...
AI workloads are pushing traditional datacentre management to its limits. Modern DCIM is now essential, using predictive ...
Dr Lovi Raj Gupta, pro vice-chancellor, Lovely Professional University, explains how aspiring professionals can equip ...
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
IM8 is the fastest-growing premium supplement brand ever recorded — over 50 million servings delivered to date, with ...
Medicare spends over $1 trillion a year and still can't keep most providers from drowning in administrative overhead while ...
The U.S. Preventive Healthcare Technologies and Services Market is projected to grow from USD 120.30 Billion in 2025 to USD ...
There is much excitement about the disruption that AI is likely to bring to traditional business workflows. This applies ...
Discover 10 remote entry-level jobs that pay $50 an hour or more. These flexible roles let you earn great money from home ...
Discover how the next generation of DMTA is creating a future-ready drug discovery engine through AI and automation.
Data show clade IIb from 2022 outbreak is 100 to 100,000-fold less virulent than clade IIa from 2003 outbreak Tonix is advancing TNX-801, a live, attenuated, minimally replicative investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results